epilepsy
Showing NaN - NaN of 48
Epilepsy, Lennox Gastaut Syndrome, Lennox-Gastaut Syndrome, Intractable Trial in United States (RNS System)
Recruiting
- Epilepsy
- +4 more
- RNS System
-
Birmingham, Alabama
- +5 more
Dec 28, 2022
Status Epilepticus, Convulsive Status EPILEPTICUS, Non Convulsive Status Epilepticus Trial in United States (IV Ganaxolone
Completed
- Status Epilepticus
- +3 more
- IV Ganaxolone active
- IV Placebo, non-active
-
Wilmington, Delaware
- +7 more
Nov 18, 2022
Study in Pediatric Early-Onset SCN2A-Developmental and Epileptic
Recruiting
- SCN2A-DEE
- Epilepsy
-
Atlanta, GeorgiaPraxis Research Site
Nov 28, 2022
Antiepileptic Drugs (MONEAD)
Active, not recruiting
- Epilepsy
- Pregnancy
-
Birmingham, Alabama
- +19 more
Aug 4, 2022
Epilepsy Trial in Atlanta (HOBSCOTCH)
Recruiting
- Epilepsy
- HOBSCOTCH
-
Atlanta, GeorgiaEmory Brain Health Center
Apr 14, 2022
RNS® System Epilepsy PAS
Active, not recruiting
- Epilepsy
- RNS System
-
Birmingham, Alabama
- +34 more
Mar 30, 2022
Childhood Absence Epilepsy, Petit Mal Epilepsy, Epilepsy Trial in United States (Ethosuximide, Lamotrigine, Valproic acid)
Completed
- Childhood Absence Epilepsy
- +3 more
- Ethosuximide
- +2 more
-
Birmingham, Alabama
- +30 more
Sep 18, 2020
Epilepsy, Depressive Symptoms, Anxiety Disorders and Symptoms Trial in Atlanta (Project UPLIFT)
Completed
- Epilepsy
- +2 more
- Project UPLIFT
-
Atlanta, GeorgiaMorehouse School of Medicine
Jun 22, 2020
Pharmacokinetics of Anti-epileptic Drugs in Obese Children
Completed
- Epilepsy
- Obese
- Anti-epileptics
-
Aurora, Colorado
- +9 more
Jun 2, 2020
Measured Prospectively in Patients Stimulated
Completed
- Epilepsy
-
Atlanta, Georgia
- +19 more
Sep 20, 2019
Epilepsy, Dravet Syndrome Trial in Worldwide (GWP42003-P 20 mg/kg/day Dose, Placebo control)
Completed
- Epilepsy
- Dravet Syndrome
- GWP42003-P 20 mg/kg/day Dose
- Placebo control
-
Miami, Florida
- +21 more
Jul 26, 2018
Epilepsy, Dravet Syndrome Trial in United Kingdom, United States (GWP42003-P 5 mg/kg/day Dose, Placebo control, GWP42003-P 10
Completed
- Epilepsy
- Dravet Syndrome
- GWP42003-P 5 mg/kg/day Dose
- +3 more
-
Miami, Florida
- +10 more
Jul 26, 2018
Epilepsy, Lennox-Gastaut Syndrome Trial in Netherlands, Poland, United States (GWP42003-P 20 mg/kg/day Dose, Placebo)
Completed
- Epilepsy
- Lennox-Gastaut Syndrome
- GWP42003-P 20 mg/kg/day Dose
- Placebo
-
Tampa, Florida
- +23 more
Jul 26, 2018
Improve Tolerance and Accelerate Adaptation
Completed
- Epilepsy
- Seizures
- Vagus Nerve Stimulation Therapy
-
Phoenix, Arizona
- +14 more
Oct 3, 2017
